Seller record · trinitymeds.com
Trinity Meds
Fails 2 of 8 criteria. S5, analytical documentation: Eight pages were read, covering home, about, contact, terms, privacy and the frequently asked questions, and none publishes a certificate of analysis, a lot number or a testing claim. 1 more criterion also fails; see the table below.
Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.
A telehealth membership selling compounded semaglutide and tirzepatide. It names four filling pharmacies with street addresses and prints one flat monthly price for each product.
Operating entity Trinity Meds, Inc.
Dispositions
| Code | Criterion | Disposition | Where it was read |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | trinitymeds.com/about |
| S2 | Prescription gating | PASS | trinitymeds.com |
| S3 | Pharmacy identification | PASS | trinitymeds.com/about |
| S4 | Compounding disclosure | PASS | trinitymeds.com/about |
| S5 | Analytical documentation | FAIL | trinitymeds.com |
| S6 | Business address | FAIL | trinitymeds.com/privacy |
| S7 | Price disclosure | PASS | trinitymeds.com |
| S8 | Enforcement status | PASS | FDA warning-letter index |
Evidence, criterion by criterion
What was read, where, and on what date, for each disposition in the table above.
Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide.
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.